In summary, we have presented evidence that USP22, an up-stream molecule of AP4, exhibits strong potential to promote CRC metastasis, particularly CRC migration and invasion capacities, both in vitro and in vivo, by inducing EMT by activating AP4. Here, USP22 is linked to colorectal carcinoma.